Tanzania Pharmaceuticals & Healthcare Q4 2018
Although we forecast the Tanzanian pharmaceutical market experience robust growth in the coming years, it will stillremain a challenging destination for multinational drugmakers. The market is limited by low per capita spending on medicines andan underdeveloped healthcare sector. Whilst demand for medicine will increase over the long-term, driven by the country’s rapidlyexpanding population and high disease burden, we expect that Tanzania's pharmaceutical sector will remain dominated by genericdrugmakers, with a majority coming from India.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook